Modifications of Medical Care of Chronic Liver Diseases During COVID-19 Pandemic: Necessity or Novelty?

Title:Modifications of Medical Care of Chronic Liver Diseases During COVID-19 Pandemic: Necessity or Novelty?

Volume: 21 Issue: 8

Author(s): Hanan Hamed Soliman, Mohamed H. Emara, Mahmoud Elkadeem and Sherief Abd-Elsalam*

Affiliation:

• Tropical Medicine and Infectious Diseases Department, Faculty of Medicine, Tanta University,Egypt

Keywords: Coronavirus disease, COVID-19, pandemic, chronic liver diseases, cirrhosis, HCC.

Abstract: In late 2019, coronavirus-2 (SARS-COV 2) infection emerged in Wuhan, China and spread to all countries making the first pandemic of the 21st century. It seems that this infection will persist which is long enough to obligate modifications in both lifestyle and health care systems. Because chronic liver diseases (CLD) are prevalent all over the world, it is expected to manage patients with CLD and COVID-19. The aim of this review was to shed light on the impact of COVID-19 pandemic on the management of patients with CLD and how to give medical care to CLD patients during COVID-19 pandemic.

Cite this article as:

Soliman Hamed Hanan , Emara H. Mohamed , Elkadeem Mahmoud and Abd-Elsalam Sherief*, Modifications of Medical Care of Chronic Liver Diseases During COVID-19 Pandemic: Necessity or Novelty?, Infectious Disorders - Drug Targets 2021; 21 (8) : e160921189886 . https://dx.doi.org/10.2174/1871526520666210104152256